April 23, 1992

In last Thursday's editions, the disposition of a U.S. District Court case involving PharmaKinetics Laboratories of Baltimore was incorrectly reported.

PharmaKinetics itself was fined $200,000 in June after pleading guilty to obstructing an agency proceeding -- a Food and Drug Administration investigation involving generic drug testing and certification.

The company's former executive vice president, Mark B. Perkal, is awaiting sentencing for his guilty plea to obstruction and aiding and abetting charges.

+ The Sun regrets the errors.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.